Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elihu H Estey

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
American Journal of Hematology|October 18, 2018
Acute myeloid leukemia: 2019 update on risk-stratification and managementElihu H Estey
Clinical Advances in Hematology & Oncology : H&O|September 22, 2005
"3+7" therapy for the treatment of acute myeloid leukemia. CONElihu H Estey
Haematologica|January 2, 2009
Treatment of acute myeloid leukemiaElihu H Estey
Best Practice & Research. Clinical Haematology|March 18, 2008
Older adults: should the paradigm shift from standard therapy?Elihu H Estey
Haematologica|June 3, 2011
Treatment of acute myeloid leukemia in the elderlyElihu H Estey
Best Practice & Research. Clinical Haematology|October 21, 2004
Modulation of angiogenesis in patients with myelodysplastic syndromeElihu H Estey
American Journal of Hematology|August 25, 2020
Acute myeloid leukemia: 2021 update on risk-stratification and managementElihu H Estey
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Primacy of resistance rather than toxicity in determining outcome of therapy for AMLElihu H Estey
American Journal of Hematology|October 17, 2014
Acute myeloid leukemia: 2014 update on risk-stratification and managementElihu H Estey
Current Oncology Reports|August 5, 2003
Early blast clearance by remission induction as a prognostic factor in acute myeloid leukemiaElihu H Estey
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
American Journal of Hematology|October 18, 2018
Acute myeloid leukemia: 2019 update on risk-stratification and managementElihu H Estey
Clinical Advances in Hematology & Oncology : H&O|September 22, 2005
"3+7" therapy for the treatment of acute myeloid leukemia. CONElihu H Estey
Haematologica|January 2, 2009
Treatment of acute myeloid leukemiaElihu H Estey
Best Practice & Research. Clinical Haematology|March 18, 2008
Older adults: should the paradigm shift from standard therapy?Elihu H Estey
Haematologica|June 3, 2011
Treatment of acute myeloid leukemia in the elderlyElihu H Estey
Best Practice & Research. Clinical Haematology|October 21, 2004
Modulation of angiogenesis in patients with myelodysplastic syndromeElihu H Estey
American Journal of Hematology|August 25, 2020
Acute myeloid leukemia: 2021 update on risk-stratification and managementElihu H Estey
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Primacy of resistance rather than toxicity in determining outcome of therapy for AMLElihu H Estey
American Journal of Hematology|October 17, 2014
Acute myeloid leukemia: 2014 update on risk-stratification and managementElihu H Estey
Current Oncology Reports|August 5, 2003
Early blast clearance by remission induction as a prognostic factor in acute myeloid leukemiaElihu H Estey
Pageof 20